Salmedix Inc
Salmedix is an oncology drug development company with a commercial focus on the treatment of hematologic malignancies, or blood cancers.
Date | Investors | Amount | Round |
---|---|---|---|
N/A | Series A | ||
$27.5m | Series B | ||
* | N/A | Acquisition | |
$45.0m | Series C | ||
Total Funding | €65.9m |